Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.

about

Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines.

P2860

Q49860442-C2E6453C-1FE8-4240-AEAE-486ACEEFA4F2

P2860

Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.

Item

http://www.wikidata.org/entity/Q38776872

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Tracking antitumor metallodrug ...... I)-cyclopentadienyl scaffolds.

@en

type

Item

label

Tracking antitumor metallodrug ...... I)-cyclopentadienyl scaffolds.

@en

prefLabel

Tracking antitumor metallodrug ...... I)-cyclopentadienyl scaffolds.

@en

P1476

Tracking antitumor metallodrug ...... I)-cyclopentadienyl scaffolds.

@en

P2093

Maria Helena Garcia

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites

The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds.

Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1

Ruthenium half-sandwich complexes as protein kinase inhibitors: an N-succinimidyl ester for rapid derivatizations of the cyclopentadienyl moiety.

Exploring the cellular accumulation of metal complexes.

Ruthenium-based chemotherapeutics: are they ready for prime time?

Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates.

Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone

Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines.

Organometallic anticancer compounds

P304

527-544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC.16.7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27096164

http://www.w3.org/2001/XMLSchema#string

Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.

about

P2860

P2860

Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698